New weight loss pill approved by the FDA

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

NEW YORK – The Food and Drug Administration has approved a new weight loss pill for the third time in the last decade.

Contrave, which works by decreasing a patient’s appetite, was approved for people who are obese or those who struggle with weight-related health problems, like diabetes.

In clinical trials, people who took Contrave in combination with a healthy diet and exercise lost two to four percent more weight than those taking a placebo.

While it did not cause massive weight loss, 42 percent of patients lost at least five percent of their body weight.

However, the drug comes with a few side effects.

Possible side effects include elevated blood pressure and heart rate, as well as an increased risk of suicidal thoughts.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.